[1]
|
X. X. Yin, Y. D. Zhang, H. T. Zhuo, J. P. Shen, L. M. Li, Q. J, “Pharmacokinetics and relative bioavailability of metformin hydrochloride sustained release tablets in healthy Chinese volunteers,”Asian J. Drug Metab. Pharmacok, Vol.4, No.2, 2004, pp.137-142.
|
[2]
|
G. Corti, M. Cirri, F. Maestrelli, N. Mennini, P. Mura, “Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl–beta-cyclodextrin,” Eur. J. Pharm. Biopharm, Vol.68, No.2, 2008, pp. 303-309.
|
[3]
|
L. D. Hu , Y. Liu, X. Tang, Q. Zhang, “Preparation and in vitro/in vivo evaluation of sustained-release met-formin hydrochloride pellets,” Eur. J. Pharma. Biopharma, Vol.64, No.2, 2006, pp.185-192.
|
[4]
|
P. J. Pentikainen, P. J. Neuvonen, A. Penttila, “Pharmacokinetics of metformin after intravenous and oral administration to man,” Eur. J. Clin. Pharmacol, Vol. 16, No. 3, 1979, pp.195-202.
|
[5]
|
G. T. Tucker, C. Casey, P. J. Phillips, H. Connor, J. D. Ward, H. F. Woods, “Metformin kinetics in healthy subjects and in patients with diabetes mellitus,” Br. J. Clin. Pharmacol, Vol. 12, No. 2, 1981, pp.235-246.
|
[6]
|
P. K. Bhoyar, D. M. Biyani, “Formulation and In vitro Evaluation of Sustained Release Dosage Form with Taste Masking of Metformin Hydrochloride,” Indian J. Pharm. Sci, Vol. 72, No. 2, 2010, pp.184-190.
|
[7]
|
O. Defang, N. Shufang, L. Wei, G. Hong, L. Hui, P. Weisan, “In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide,” Drug Dev. Ind. Pharm, Vol. 31, No. 7, 2005, pp.677-685.
|
[8]
|
A. Ghosh, A. Bose, U. Bhaumik, “Application of Response Surface Methodology in the Formulation of Sustained Release Matrix Tablets of Metformin Hydrochloride,” Asian J. Chem, Vol. 20, No. 7, 2008, pp. 5541-5556.
|
[9]
|
J. Piao, J. E. Lee, K.Y. Weon, D. W. Kim, J. S. Lee, J. D. Park, Y. Nishiyama, I. Fukui, J. S. Kim, “Development of novel mucoadhesive pellets of metformin hydrochloride,” Arch. Pharm. Res, Vol. 32, No. 3, 2009, pp. 391-397.
|
[10]
|
P. Subhedar, J. B. Naik, D. N. Muley, “Effect of Polymer Concentration on Sustained Release Microparticles of Metformin Hydrochloride Prepared by Using Spray Dryer,” Polymer-Plast. Technol, Vol. 49, No. 1-3, 2010, pp. 267-271.
|
[11]
|
H. F. Liu, X. Y. Su, X. Li, X. Zhao, L. Zang, W. S. Pan, “Development of Prolonged Release Microspheres of Metformin Hydrochloride Using Ion Exchange Resins,” J. Chinese Pharmaceu. Sci, Vol. 15, No. 3, 2006, pp. 155-161.
|
[12]
|
S. P. Boldhane, B. S. Kuchekar, “Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design,” Current drug deliver, Vol. 6, No. 5, 2009, pp. 477-485.
|
[13]
|
G. Di Colo, S. Falchi, Y. Zambito, “In vitro evaluation of a system for pH-controlled peroral delivery of metformin,” J. Contro. Rel, Vol. 80, No. 1-3, 2002, pp. 119-128.
|
[14]
|
P. C. Wu, M. J. Tsai, Y. B. Huang, J. S. Chang, Y. H. Tsai, “In vitro and in vivo evaluation of potassium chloride sustained release formulation prepared with saturated polyglycolyed glycerides matrices,” Int. J. Pharm, Vol. 243, No. 1-2, 2002, pp. 119-124.
|
[15]
|
J. E. Polli, G. S. Rekhi, L L. Augsburger, V. P. Shah, “Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets,”J. Pharm. Sci. Vol. 86, No. 6, 1997, pp. 690-700.
|
[16]
|
S.G. Wang, L. Wang, Z. Z. Shao, X. P. Lu, X. Q. Hang, “Study on the release rate of niacin in different media for the compound niacin extended-release and simvastatin tablets,”Chinese J. Pharmaco, Vol. 8, No. 10, 2011, pp. 581-584.
|
[17]
|
N. A. Peppas, “Analysis of Fickian and non-Fickian drug release from polymers,” Vol. 60, No. 4, 1985, pp. 110-111.
|